Cardiovascular Effects of Salvianolic Acid B

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Cells/tissues</td><td align="left">Effects</td><td align="center">Reference</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">HUVEs<br/></td><td align="left">Expression of MMP-2 gene,<br/>expression of VEGF,<br/>VEGF gene,<br/>VEGF receptor 2 genes.</td><td align="center">
									Lay et al., 2003 [<a href="/journals/ecam/2013/247948/#B30">30</a>]</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>Note: VEGF: vascular endothelial growth factor receptor; MMP-2: matrix metalloproteinase-2; HUVEC: human umbilical vein endothelial cells.<br/></td></tr></table>

Promoting cardiac angiogenesis effect of salvianolic acid B in vitro.

Evidence-Based Complementary and Alternative Medicine

tab3

Table 3

Table 3: Cardiovascular Effects of Salvianolic Acid B 